As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine ...
Austin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Growth Analysis According to SNS Insider, the global Enzyme-Linked Immunosorbent Assay (ELISA) Market ...
SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological ...
Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Enzyme-Linked Immunosorbent Assay (ELISA) Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The ...
New application for AroCell TK 210 ELISA opens new opportunities for drug development research AroCell AB (publ) announces today that an abstract submitted by Kiran Kumar Jagarlamudi et al entitled ...
(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider projects the U.S. Enzyme-Linked Immunosorbent Assay (ELISA) Market to grow from USD 0.71 billion in 2025E to USD 1.10 billion by 2033, at a CAGR of 5.69%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results